Pfizer (PFE): Exploring Valuation as Shares Tick Higher Despite Sector Headwinds

Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

What’s Behind The Slump In Pfizer Stock?

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...
Hosted on MSN

Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings

Opdivo’s sales rose 9% to $4.82 billion in the first half of 2025. PFE’s Price Performance, Valuation and Estimates Pfizer’s stock has declined 1.0% so far this year against an increase of 8.0% for ...
GEN - Genetic Engineering and Biotechnology News

StockWatch: Pfizer’s Deal with Trump Pays off for Investors

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million

According to a Securities and Exchange Commission (SEC) filing dated October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV ...